Windlas Biotech Restores Operations After Labour Unrest

1 min read     Updated on 19 May 2026, 06:55 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Windlas Biotech experienced a temporary halt in operations at its Dehradun manufacturing sites on May 18, 2026, due to labour protests across Uttarakhand. The company confirmed that production resumed by the evening shift and that there is no anticipated material impact on its financial performance or supply chain.

powered bylight_fuzz_icon
40685111

*this image is generated using AI for illustrative purposes only.

Windlas Biotech has informed stock exchanges of a temporary disruption in operations at certain of its manufacturing sites on May 18, 2026, following a statewide labour unrest situation in Uttarakhand. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/CFD/PoD2/CIR/P/2026/14 dated January 30, 2026.

Labour Unrest Across Uttarakhand

The labour protest was triggered across various industrial areas in the state, including Dehradun and Haridwar, leading to work stoppages at multiple manufacturing plants across several industries. The statewide nature of the unrest affected operations at Windlas Biotech's manufacturing sites, which are located in the Mohabewala Industrial Area, Dehradun.

Operational Impact and Restoration

The following table summarises the key details of the incident as disclosed by the company:

Parameter: Details
Date of Disruption: May 18, 2026
Nature of Event: Statewide labour unrest and work stoppage
Affected Locations: Certain manufacturing sites in Dehradun
Status of Operations: Restored by evening shift on May 18, 2026
Material Impact on Financials: Not envisaged by the company

Production was restored by the evening shift on the same day, and operations have since resumed across all sites. The company stated that it currently does not envisage any material impact on its operations, supply chain, or financial performance as a result of this disruption.

Administration and Monitoring

The local administration and relevant authorities are actively engaging in the region to facilitate an early restoration of normalcy. Windlas Biotech's management has stated that the situation is being closely monitored. The disclosure was signed by Ananta Narayan Panda, Company Secretary and Compliance Officer, on May 18, 2026.

If labour unrest in Uttarakhand recurs or escalates, could Windlas Biotech consider diversifying its manufacturing footprint to other states to reduce concentration risk?

How might repeated labour disruptions in Uttarakhand's industrial zones affect the state's attractiveness for pharmaceutical manufacturing investments going forward?

Could this statewide labour unrest lead to wage revisions or policy changes in Uttarakhand that may structurally increase operating costs for pharma manufacturers like Windlas Biotech?

Windlas Biotech Completes Buyback of 4,70,000 Equity Shares at INR 1,000 Per Share

6 min read     Updated on 19 May 2026, 02:23 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Windlas Biotech Limited completed its share buyback programme with the extinguishment of 4,70,000 equity shares on May 18, 2026, at INR 1,000 per share, deploying INR 47,00,00,000 excluding transaction costs. The buyback was oversubscribed 5.65 times with 9,857 valid bids received for 26,57,484 shares, and promoter shareholding rose to 63.31% post-buyback. The Post Buyback Public Announcement dated May 15, 2026 was published across Financial Express, Jansatta, and Dainik Bhaskar on May 16, 2026.

powered bylight_fuzz_icon
40461805

*this image is generated using AI for illustrative purposes only.

Windlas Biotech Limited has completed the extinguishment of 4,70,000 (Four Lakh Seventy Thousand) fully paid-up equity shares of face value INR 5 each on May 18, 2026, marking the final step in its share buyback programme. The extinguishment was carried out in dematerialised form through National Securities Depository Limited (NSDL), with confirmation received on May 18, 2026. No equity shares were tendered or extinguished in physical form. The completion follows the buyback's tendering period, which ran from April 30, 2026 to May 07, 2026, during which the company repurchased shares at INR 1,000 per equity share through the tender offer route, utilising a total amount of INR 47,00,00,000 (Indian Rupees Forty Seven Crore Only), excluding transaction costs. A Post Buyback Public Announcement dated May 15, 2026 was published on May 16, 2026 in Financial Express (English, All Editions), Jansatta (Hindi, All Editions), and Dainik Bhaskar (Hindi, Dehradun Edition).

Buyback Programme Overview

The Board of Directors approved the buyback at its meeting on April 17, 2026. The Public Announcement was dated April 18, 2026 and published on April 20, 2026, followed by the Letter of Offer dated April 27, 2026 and the Offer Opening Advertisement dated April 28, 2026, published on April 29, 2026. The Record Date for determining eligible shareholders was April 24, 2026, and BSE served as the designated stock exchange. The buyback represented 2.23% of the total equity shares in the existing total paid-up equity share capital, and the Buyback Offer Size represented 9.80% of the aggregate of the total paid-up equity share capital and free reserves (including securities premium) based on the latest audited standalone and consolidated financial statements as at March 31, 2025.

Parameter: Details
Buyback Price: INR 1,000 per equity share
Total Shares Bought Back: 4,70,000 equity shares
Total Amount Utilised: INR 47,00,00,000 (excl. transaction costs)
Face Value per Share: INR 5.00
% of Total Paid-up Capital: 2.23%
Buyback Offer Size (% of capital & reserves): 9.80% (standalone and consolidated)
Record Date: April 24, 2026
Tendering Period: April 30, 2026 – May 07, 2026
Designated Stock Exchange: BSE
Date of Extinguishment: May 18, 2026

Capital Structure and Share Capital Reconciliation

The company's authorised share capital comprises 108,000,000 equity shares of face value INR 5 each (₹540.00 million), 300,000,000 Non-Cumulative Compulsory Convertible Preference Shares of face value INR 100 each (₹30.00 million), and 20,500,000 Optionally Convertible Preference Shares of INR 10 each (₹205.00 million), totalling ₹775.00 million. With the extinguishment now complete, the company's paid-up equity share capital has been formally reduced. The table below presents the reconciliation of share capital before and after the buyback:

Sr. No.: Particulars: No. of Equity Shares: Equity Share Capital (In INR):
1. Paid-up equity share capital (Pre-Buyback) 2,11,06,229 10,55,31,145
2. Less: Total Equity Shares (Demat) extinguished 4,70,000 23,50,000
3. Less: Total Equity Shares (Physical) extinguished
4. Paid-up equity share capital (Post Buyback) 2,06,36,229 10,31,81,145

The extinguishment was executed through SMC Global Securities Limited (DP ID: IN303655) as the Depository Participant, with NSDL as the depository and Company Client ID No. 10340791. The NSDL confirmation letter dated May 18, 2026 confirmed the debit of 4,70,000 equity shares (ISIN: INE0H5O01029) with an execution date of May 16, 2026.

Bid Response and Settlement

The buyback received strong investor interest. MUFG Intime India Private Limited, the Registrar to the Buyback, considered a total of 9,857 valid bids for 26,57,484 (Twenty Six Lakh Fifty Seven Thousand Four Hundred Eighty Four) equity shares, representing approximately 5.65 times the maximum number of equity shares proposed to be bought back. The following table details the category-wise bid response:

Category: Shares Reserved Valid Bids Received Shares Validly Tendered Response (in times)
Reserved Category (Small Shareholders): 97,342 8,862 2,00,518 2.06
General Category (All Other Eligible Shareholders): 3,72,658 995 24,56,966 6.59
Total: 4,70,000 9,857 26,57,484 5.65

Communication of acceptance or rejection was sent by the Registrar to eligible shareholders on May 14, 2026. Settlement of all valid bids was completed by the Clearing Corporation on May 14, 2026, with direct funds payout made to eligible shareholders. Unaccepted dematerialised equity shares were returned to respective Seller Members or Custodians on the same date.

Shareholding Pattern: Pre and Post Buyback

The buyback has resulted in a notable shift in the shareholding pattern. Promoters and persons acting in concert held 1,30,65,352 shares (61.90%) before the buyback, with their percentage shareholding rising to 63.31% post-extinguishment as the total share count reduces. The table below summarises the pre and post-buyback shareholding pattern as on the Record Date of April 24, 2026:

Shareholder Category: Pre-Buyback Shares Pre-Buyback % Post-Buyback Shares* Post-Buyback %
Promoters and persons acting in concert: 1,30,65,352 61.90 1,30,65,352 63.31
Foreign Investors (OCBs/FIIs/NRIs/Non-residents/Non-domestic companies): 4,66,484 2.21 75,70,877 36.69
Indian Financial Institutions/Banks/Mutual Funds/Govt. Companies: 24,52,250 11.62
Public including other Bodies Corporate: 51,22,143 24.27
Total: 2,11,06,229 100.00 2,06,36,229 100.00

*Post Extinguishment of 4,70,000 Equity Shares

Major Shareholders Participating in the Buyback

The following eligible shareholders had equity shares exceeding 1% of the total equity shares accepted under the buyback:

Sr. No.: Shareholder Name: Shares Accepted: % of Total Buyback: % of Post-Buyback Capital:
1: ICICI Prudential Smallcap Fund 1,44,516 30.75 0.70
2: Perpetuity Health to Wealth (H2W) Rising Fund 34,160 7.27 0.17
3: Ajay Kumar Aggarwal 24,857 5.29 0.12
4: UTI-Healthcare Fund 18,461 3.93 0.09
5: Vaikarya Change India Fund 7,469 1.59 0.04
6: Micro Strategies Fund 7,406 1.58 0.04
7: Legends Global Opportunities (Singapore) Pte. Ltd. 6,832 1.45 0.03
8: Rakesh Kumar Sharma 4,842 1.03 0.02

Certification and Regulatory Compliance

The Certificate of Extinguishment dated May 18, 2026 was duly certified and verified by MUFG Intime India Private Limited (Registrar to the Buyback), M/s. Sandeep Joshi & Associates, Company Secretaries (Secretarial Auditor), and the Company, in compliance with Regulation 11 of the SEBI (Buy-back of Securities) Regulations, 2018. The extinguishment was carried out in accordance with the provisions of the Companies Act, 2013, SEBI (Depositories and Participants) Regulations, 2018, and other applicable provisions. Fintellectual Corporate Advisors Private Limited, based in Noida, Uttar Pradesh (SEBI Registration No.: INM000012944), served as the Manager to the Buyback. The announcement was signed by Managing Director Hitesh Windlass, Joint Managing Director Manoj Kumar Windlass, and Company Secretary and Compliance Officer Ananta Narayan Panda.

How might Windlas Biotech's increased promoter shareholding of 63.31% influence its future corporate governance decisions and minority shareholder rights?

Given the 5.65x oversubscription of the buyback, does Windlas Biotech plan to announce additional buyback programmes or alternative capital return mechanisms in the near term?

How will the reduction in free float following the buyback impact Windlas Biotech's liquidity and institutional investor interest in the stock?

More News on Windlas Biotech